Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

143 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Determinants of approved acetylcholinesterase inhibitor response outcomes in Alzheimer's disease: relevance for precision medicine in neurodegenerative diseases.
Lista S, Vergallo A, Teipel SJ, Lemercier P, Giorgi FS, Gabelle A, Garaci F, Mercuri NB, Babiloni C, Gaire BP, Koronyo Y, Koronyo-Hamaoui M, Hampel H, Nisticò R; Neurodegeneration Precision Medicine Initiative (NPMI). Lista S, et al. Among authors: giorgi fs. Ageing Res Rev. 2023 Feb;84:101819. doi: 10.1016/j.arr.2022.101819. Epub 2022 Dec 13. Ageing Res Rev. 2023. PMID: 36526257 Review.
Treatment of epilepsy in patients with Alzheimer's disease.
Giorgi FS, Guida M, Vergallo A, Bonuccelli U, Zaccara G. Giorgi FS, et al. Expert Rev Neurother. 2017 Mar;17(3):309-318. doi: 10.1080/14737175.2017.1243469. Epub 2016 Oct 11. Expert Rev Neurother. 2017. PMID: 27687685 Review.
Oxidative Stress Assessment in Alzheimer's Disease: A Clinic Setting Study.
Vergallo A, Giampietri L, Baldacci F, Volpi L, Chico L, Pagni C, Giorgi FS, Ceravolo R, Tognoni G, Siciliano G, Bonuccelli U. Vergallo A, et al. Among authors: giorgi fs. Am J Alzheimers Dis Other Demen. 2018 Feb;33(1):35-41. doi: 10.1177/1533317517728352. Epub 2017 Sep 21. Am J Alzheimers Dis Other Demen. 2018. PMID: 28931301 Free PMC article.
Precision medicine and drug development in Alzheimer's disease: the importance of sexual dimorphism and patient stratification.
Hampel H, Vergallo A, Giorgi FS, Kim SH, Depypere H, Graziani M, Saidi A, Nisticò R, Lista S; Alzheimer Precision Medicine Initiative (APMI). Hampel H, et al. Among authors: giorgi fs. Front Neuroendocrinol. 2018 Jul;50:31-51. doi: 10.1016/j.yfrne.2018.06.001. Epub 2018 Jun 12. Front Neuroendocrinol. 2018. PMID: 29902481 Review.
Basal Forebrain Volume, but Not Hippocampal Volume, Is a Predictor of Global Cognitive Decline in Patients With Alzheimer's Disease Treated With Cholinesterase Inhibitors.
Teipel SJ, Cavedo E, Hampel H, Grothe MJ; Alzheimer's Disease Neuroimaging Initiative; Alzheimer Precision Medicine Initiative (APMI). Teipel SJ, et al. Front Neurol. 2018 Aug 14;9:642. doi: 10.3389/fneur.2018.00642. eCollection 2018. Front Neurol. 2018. PMID: 30158893 Free PMC article.
The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases.
Baldacci F, Mazzucchi S, Della Vecchia A, Giampietri L, Giannini N, Koronyo-Hamaoui M, Ceravolo R, Siciliano G, Bonuccelli U, Elahi FM, Vergallo A, Lista S, Giorgi FS, Hampel H. Baldacci F, et al. Among authors: giorgi fs. Expert Rev Mol Diagn. 2020 Apr;20(4):421-441. doi: 10.1080/14737159.2020.1731306. Epub 2020 Feb 27. Expert Rev Mol Diagn. 2020. PMID: 32066283 Free PMC article. Review.
β-Secretase1 biological markers for Alzheimer's disease: state-of-art of validation and qualification.
Hampel H, Lista S, Vanmechelen E, Zetterberg H, Giorgi FS, Galgani A, Blennow K, Caraci F, Das B, Yan R, Vergallo A; Alzheimer’s Precision Medicine Initiative (APMI). Hampel H, et al. Among authors: giorgi fs. Alzheimers Res Ther. 2020 Oct 16;12(1):130. doi: 10.1186/s13195-020-00686-3. Alzheimers Res Ther. 2020. PMID: 33066807 Free PMC article. Review.
143 results